SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-011758
Filing Date
2023-04-10
Accepted
2023-04-10 17:18:55
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 120470
2 ex31-1.htm EX-31.1 16317
3 ex31-2.htm EX-31.2 16715
4 ex32.htm EX-32 13157
  Complete submission text file 0001493152-23-011758.txt   494038

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20221231.xsd EX-101.SCH 25836
6 XBRL LABEL FILE abeo-20221231_lab.xml EX-101.LAB 99442
7 XBRL PRESENTATION FILE abeo-20221231_pre.xml EX-101.PRE 23766
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7074
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-15771 | Film No.: 23811825
SIC: 2834 Pharmaceutical Preparations